Home > Boards > US Listed > Biotechs > KemPharm Inc. (KMPH)

Unfortunately, the infrastructure bill does not lower the

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
gi197845 Member Profile
 
Followed By 4
Posts 2,659
Boards Moderated 1
Alias Born 08/16/16
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/29/2021 4:11:46 PM
KemPharm to Present at the Benzinga Healthcare Small Cap Conference GlobeNewswire Inc. - 9/27/2021 7:30:00 AM
KemPharm to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference GlobeNewswire Inc. - 9/23/2021 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/20/2021 5:03:46 PM
KemPharm to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference GlobeNewswire Inc. - 9/9/2021 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/1/2021 4:04:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/30/2021 5:10:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/24/2021 4:52:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/24/2021 4:49:40 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/24/2021 4:28:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/24/2021 4:27:00 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 8/20/2021 5:05:31 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/18/2021 5:38:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/18/2021 5:02:31 PM
KemPharm Appoints Tamara A. Seymour to Board of Directors GlobeNewswire Inc. - 8/18/2021 4:45:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2021 5:02:50 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 8/13/2021 7:40:21 AM
KemPharm Reports Second Quarter 2021 Financial Results GlobeNewswire Inc. - 8/12/2021 4:05:00 PM
KemPharm to Report Second Quarter 2021 Results GlobeNewswire Inc. - 8/5/2021 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/21/2021 8:46:55 AM
KemPharm Announces U.S. Launch of Innovative ADHD Treatment AZSTARYS™ (serdexmethylphenidate and dexmethylphenidate capsule... GlobeNewswire Inc. - 7/21/2021 8:30:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 7/12/2021 4:18:49 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 7/7/2021 4:51:06 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 7/2/2021 4:32:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2021 4:02:36 PM
gi197845   Wednesday, 08/11/21 01:09:05 PM
Re: gi197845 post# 762
Post # of 771 
Unfortunately, the infrastructure bill does not lower the costs in dealing with NDA and sNDA submussions to the FDA, nor does it lower the costs of running new drug trials...

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences